Acadia Healthcare(ACHC) - 2025 Q4 - Annual Results

Financial Guidance - Revenue guidance for 2025 is projected to be between $3.28 billion and $3.30 billion[8] - Adjusted EBITDA is expected to be in the range of $601 million to $611 million for 2025[8] - Adjusted earnings per share are forecasted to be between $1.94 and $2.04[8] - The company is reaffirming its financial guidance provided in the November 5, 2025 earnings release[6] Events and Presentations - The company will participate in the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026[5] - The live webcast of the presentation will be available on the company's website[6] Operational Risks - Potential risks include difficulties in integrating acquired facilities and changes in Medicaid financing mechanisms[9] - The company is subject to regulatory risks that could impact its stock price and operational costs[9] Business Operations - The company operates acute inpatient psychiatric facilities and outpatient behavioral healthcare services across the U.S. and Puerto Rico[10] - The company emphasizes the importance of cash generation to service its debt and meet capital requirements[9]

Acadia Healthcare(ACHC) - 2025 Q4 - Annual Results - Reportify